Published In
European Journal of Rheumatology
Volume 5 · Issue 1
Pages: 58-61
History
Published Online: September 3, 2019
Zahava Vadasz
Department of Allergy and Clinical Immunology, Bnai-Zion Medical Center, Haifa, Israel
Elias Toubi
Department of Allergy and Clinical Immunology, Bnai-Zion Medical Center, Haifa, Israel
Vadasz, Z., & Toubi, E. (2019). Semaphorin3A: A potential therapeutic tool in immune-mediated diseases. European Journal of Rheumatology, 5(1), 58–61. https://doi.org/10.5152/eurjrheum.2017.17076
Full Text
Full Text PDF
Full Text PDF
Abstract
Abstract
The significance of semaphorin3A (sema3A) in regulating immune-mediated inflammation is widely reported. There are multiple mechanisms involved in the process of sema3A-mediated regulation. One of them is the ability of sema3A to maintain a sufficient regulation of both T-cell and B-cell activation. Because it is involved in the pathogenesis of many autoimmune, infectious, and malignant diseases, sema3A turns to be a promising therapeutic tool to be studied and applied in these diseases.
Cite this article as: Vadasz Z, Toubi E. Semaphorin3A: A potential therapeutic tool in immune-mediated disases. Eur J Rheumatol 2018; 5: 58-61.
Article Info
Published In
Journal
European Journal of Rheumatology
Volume / Issue
Volume 5 · Issue 1
Pages
58-61
History
Published Online
September 3, 2019
Affiliations
Zahava Vadasz
Department of Allergy and Clinical Immunology, Bnai-Zion Medical Center, Haifa, Israel
Elias Toubi
Department of Allergy and Clinical Immunology, Bnai-Zion Medical Center, Haifa, Israel
Cite this Article
Vadasz, Z., & Toubi, E. (2019). Semaphorin3A: A potential therapeutic tool in immune-mediated diseases. European Journal of Rheumatology, 5(1), 58–61. https://doi.org/10.5152/eurjrheum.2017.17076
Outlines